Component
Human carnitine-acylcarnitine translocase / SLC25A20
Context-specific entity; species, compartment and exposure are stated on each claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
The human SLC25A20 p.Arg133Trp substitution impaired carrier activity after bacterial expression and liposome reconstitution.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Functional variant study within a six-patient CACT-deficiency report.
- limitations
- CACT deficiency is distinct from OCTN2 deficiency; supplying substrate does not replace a transporter.
- nutrient_topic
- L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
- plain_language
- A second transport defect can block the mitochondrial shuttle even when carnitine exists.
- primary_references
- Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15365988/ · DOI 10.1002/humu.20085
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 122–128
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Functional variant study within a six-patient CACT-deficiency report. · source_derived_draft · unverified_draft
## l-carnitine-cact-loss A second transport defect can block the mitochondrial shuttle even when carnitine exists. The human SLC25A20 p.Arg133Trp substitution impaired carrier activity after bacterial expression and liposome reconstitution. Model: Functional variant study within a six-patient CACT-deficiency report. Limitations: CACT deficiency is distinct from OCTN2 deficiency; supplying substrate does not replace a transporter. Evidence access: Primary abstract Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15365988/ · DOI 10.1002/humu.20085
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.